Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 52 (2), 137-148
- https://doi.org/10.1016/s0167-8140(99)00087-0
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The CHART Regimen and MorbidityActa Oncologica, 1999
- Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchusClinical Oncology, 1997
- 231A phase III study of conventional and accelerated radiotherapy (RT) with and without carboplatin in unresectable non small cell lung cancer (NSCLC)Radiotherapy and Oncology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1995
- Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus reportLung Cancer, 1994
- The chart trials: Bayesian design and monitoring in practiceStatistics in Medicine, 1994
- Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchusClinical Oncology, 1991
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991
- Radiotherapy employing three fractions in each day over a continuous period of 12 daysThe British Journal of Radiology, 1986